These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 24730676)
1. Efficacy of micafungin in pediatric immunocompromised patients with invasive fungal infection. Hashii Y; Kusuki S; Takizawa S; Tokimasa S; Ohta H; Hara J; Ozono K Pediatr Int; 2014 Dec; 56(6):834-837. PubMed ID: 24730676 [TBL] [Abstract][Full Text] [Related]
2. Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm. Aikawa N; Kusachi S; Oda S; Takesue Y; Tanaka H J Infect Chemother; 2009 Aug; 15(4):219-27. PubMed ID: 19688240 [TBL] [Abstract][Full Text] [Related]
3. [Micafungin in pediatric and adolescent patients]. Madero-López L Rev Iberoam Micol; 2009 Mar; 26(1):62-4. PubMed ID: 19463279 [TBL] [Abstract][Full Text] [Related]
4. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi]. Salavert-Lletí M; Zaragoza-Crespo R Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284 [TBL] [Abstract][Full Text] [Related]
5. Micafungin use in children. Emiroglu M Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789 [TBL] [Abstract][Full Text] [Related]
6. [Micafungin: experimental therapy of fungal infections in animal models]. Javier Pastor F; Guarro J Rev Iberoam Micol; 2009 Mar; 26(1):42-8. PubMed ID: 19463276 [TBL] [Abstract][Full Text] [Related]
7. Micafungin for the treatment of invasive aspergillosis. Enoch DA; Idris SF; Aliyu SH; Micallef C; Sule O; Karas JA J Infect; 2014 Jun; 68(6):507-26. PubMed ID: 24480373 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT. El-Cheikh J; Venton G; Crocchiolo R; Fürst S; Faucher C; Granata A; Oudin C; Coso D; Bouabdallah R; Vey N; Duran S; Fougereau E; Berger P; Chabannon C; Blaise D Bone Marrow Transplant; 2013 Nov; 48(11):1472-7. PubMed ID: 23749104 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis. Maximova N; Schillani G; Simeone R; Maestro A; Zanon D Adv Ther; 2017 May; 34(5):1184-1199. PubMed ID: 28429246 [TBL] [Abstract][Full Text] [Related]
10. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Zaoutis TE; Jafri HS; Huang LM; Locatelli F; Barzilai A; Ebell W; Steinbach WJ; Bradley J; Lieberman JM; Hsiao CC; Seibel N; Laws HJ; Gamba M; Petrecz M; Taylor AF; Strohmaier KM; Chow JW; Kartsonis NA; Ngai AL Pediatrics; 2009 Mar; 123(3):877-84. PubMed ID: 19255017 [TBL] [Abstract][Full Text] [Related]
11. Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial. Timsit JF; Azoulay E; Schwebel C; Charles PE; Cornet M; Souweine B; Klouche K; Jaber S; Trouillet JL; Bruneel F; Argaud L; Cousson J; Meziani F; Gruson D; Paris A; Darmon M; Garrouste-Orgeas M; Navellou JC; Foucrier A; Allaouchiche B; Das V; Gangneux JP; Ruckly S; Maubon D; Jullien V; Wolff M; JAMA; 2016 Oct; 316(15):1555-1564. PubMed ID: 27706483 [TBL] [Abstract][Full Text] [Related]
12. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients. Carter NJ; Keating GM Paediatr Drugs; 2009; 11(4):271-91. PubMed ID: 19566111 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials. Chen Q; Lin MH; Chen ML; Liu ZY; Chai D; Wang R Chin Med J (Engl); 2012 Jan; 125(2):345-51. PubMed ID: 22340571 [TBL] [Abstract][Full Text] [Related]
14. Antifungal prophylaxis with micafungin in patients treated for childhood cancer. Kusuki S; Hashii Y; Yoshida H; Takizawa S; Sato E; Tokimasa S; Ohta H; Ozono K Pediatr Blood Cancer; 2009 Oct; 53(4):605-9. PubMed ID: 19533659 [TBL] [Abstract][Full Text] [Related]
15. [Micafungin in invasive candidiasis among oncohematological patients]. Jarque I; Angel Sanz M Rev Iberoam Micol; 2009 Mar; 26(1):75-7. PubMed ID: 19463282 [TBL] [Abstract][Full Text] [Related]
16. Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study. Viscoli C; Bassetti M; Castagnola E; Cesaro S; Menichetti F; Ratto S; Tascini C; Giacobbe DR BMC Infect Dis; 2014 Dec; 14():725. PubMed ID: 25551699 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of micafungin for the treatment of patients with proven or probable invasive aspergillosis: A non-comparative, multicenter, phase IV, open-label study. Ji Y; Song Y; Zhou F; Liu T; Jiang M; Zhao X; Huang X Medicine (Baltimore); 2017 Dec; 96(52):e9443. PubMed ID: 29384927 [TBL] [Abstract][Full Text] [Related]
18. Caspofungin therapy in immunocompromised children and neonates. Somer A; Törün SH; Salman N Expert Rev Anti Infect Ther; 2011 Mar; 9(3):347-55. PubMed ID: 21417874 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study. Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388 [TBL] [Abstract][Full Text] [Related]
20. Echinocandins: the newest class of antifungals. Sucher AJ; Chahine EB; Balcer HE Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]